Cytoprotective Effect of Biofield Energy Treated Test Item against tert-butyl Hydroperoxide (t-BHP)-Induced Cell Damage in HepG2 Cell-line
Keywords:
the trivedi effect#xAE;, HepG2, liver health, interleukin-8, ALT, cholesterol, albumin
Abstract
Emerging data indicate that the mortality rate is rising due to liver disorders day-by-day in the developed countries. The present study was conducted to evaluate the potential of the Biofield Energy (The Trivedi Effect ® ) Treated test item (DMEM) in HepG2 cell-line. The test item was divided into two parts. One part of the test item received Consciousness Energy Healing Treatment by a renowned Biofield Energy Healer, Alice Branton and was labeled as the Biofield Energy Treated DMEM and the other part defined as untreated DMEM, where no Biofield Treatment was provided. Cell viability of the test items using MTT assay showed 113% and 129.9% viable cells in the untreated DMEM and Biofield Energy Treated DMEM groups, respectively suggested that the test items were nontoxic and safe in nature. The Biofield Energy Treated DMEM showed significant (p≤0.001) protection of cells by 15% against oxidative stress induced by t-BHP, while untreated DMEM group showed 0.4% protection.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
References
Michael Kew (2014) Hepatocellular carcinoma: epidemiology and risk factors. 1, 115.
S Vidyashankar, K Nandakumar (2010) Liv.52 protects HepG2 cells from oxidative damage induced by tert-butyl hydroperoxide. 333, 41-48.
Min-Kyung Kim, Huyn-Sun Lee, Eun-Jin Kim, Nam-Hee Won, Young-Min Chi, Byoung-Chul Kim, Kwang-Won Lee (2007) Protective effect of aqueous extract of Perilla frutescens on tert-butyl hydroperoxide-induced oxidative hepatotoxicity in rats. 45(9), 1738-1744.
B Jessen, J Mullins, A De Peyster, G Stevens (2003) Assessment of Hepatocytes and Liver Slices as in Vitro Test Systems to Predict in Vivo Gene Expression. 75(1), 208-222.
S Duthie, W Melvin, M Burke (1994) Bromobenzene detoxification in the human liver-derived HepG2 cell line. 24(3), 265-279.
S Sassa, O Sugita, R Galbraith, A Kappas (1987) Drug metabolism by the human hepatoma cell, HepG2. 143, 52-57.
Susan Lutgendorf, Elizabeth Mullen-Houser, Daniel Russell, Koen Degeest, Geraldine Jacobson, Laura Hart, David Bender, Barrie Anderson, Thomas Buekers, Michael Goodheart, Michael Antoni, Anil Sood, David Lubaroff (2010) Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach. 24(8), 1231-1240.
Gail Ironson, Tiffany Field, Frank Scafidi, Michiyo Hashimoto, Mahendra Kumar, Adarsh Kumar, Alicia Price, Alex Goncalves, Iris Burman, Cy Tetenman, Roberto Patarca, Mary Fletcher (1996) Massage Therapy is Associated with Enhancement of the Immune System's Cytotoxic Capacity. 84(1-4), 205-217.
Mahendra Trivedi, Rama Tallapragada (2008) A transcendental to changing metal powder characteristics. 63(9), 22-31.
M Trivedi, G Nayak, S Patil, R Tallapragada, O Latiyal (2015) Studies of the atomic and crystalline characteristics of ceramic oxide nano powders after bio field treatment. 4, 161.
M Trivedi, G Nayak, S Patil, R Tallapragada, O Latiyal (2015) Effect of biofield energy treatment on physical and structural properties of calcium carbide and praseodymium oxide. 4, 390-395.
M Trivedi, A Branton, D Trivedi, G Nayak, Mondal (2015) Morphological characterization, quality, yield and DNA fingerprinting of biofield energy treated alphonso mango (Mangifera indica L.). 3, 245-250.
Mahendra Trivedi, Alice Dahryn Trivedi, Gopal Sambhu Charan, Mondal Snehasis Jana (2015) Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobacter braakii: A Urinary Pathogen. 03(01), 129.
M Trivedi, S Patil, H Shettigar, Mondal, Jana (2015) Evaluation of biofield modality on viral load of Hepatitis B and C viruses. 7, 83-88.
M Trivedi, S Patil, H Shettigar, Mondal, Jana (2015) An impact of biofield treatment: Antimy cobacterial susceptibility potential using BACTEC 460 / MGIT-TB System. 5, 189.
M Trivedi, S Patil, H Shettigar, K Bairwa, Jana (2015) Phenotypic and biotypic characterization of Klebsiella oxytoca: An impact of biofield treatment. 7, 203-206.
G Nayak, N Altekar (2015) Effect of biofield treatment on plant growth and adaptation. 1, 1-9.
M Trivedi, A Branton, D Trivedi, G Nayak, Plikerd (2017) A Systematic study of the biofield energy healing treatment on physicochemical, thermal, structural, and behavioral properties of magnesium gluconate. 2, 135-145.
V Parulkar, M Trivedi, A Branton, D Trivedi, G Nayak (2018) Improved metabolism of vitamin d3 in human osteoblasts cells after biofield energy healing treatment. 3, 11-19.
M Trivedi, S Patil, H Shettigar, Mondal, Jana (2015) The potential impact of biofield treatment on human brain tumor cells: A time-lapse video microscopy. 4, 141.
Mahendra Trivedi, Shrikant Harish Shettigar, Mayank Snehasis Jana (2015) In Vitro Evaluation of Biofield Treatment on Cancer Biomarkers Involved in Endometrial and Prostate Cancer Cell Lines. 07(08), 253-257.
Alice Branton, Jana (2017) The Influence of Energy of Consciousness Healing Treatment on Low Bioavailable Resveratrol in Male Sprague Dawley Rats. 3(3), 9.
Alice Branton, Jana (2017) The Use of Novel and Unique Biofield Energy Healing Treatment for the Improvement of Poorly Bioavailable Compound, Berberine in Male Sprague Dawley Rats. 5(4), 138.
A Branton, Jana (2017) Effect of The biofield energy healing treatment on the pharmacokinetics of 25-hydroxyvitamin D3 [25(OH)D 3 ] in rats after a single oral dose of vitamin D3. 2, 11-18.
V Parulkar, M Trivedi, A Branton, D Trivedi, G Nayak (2017) The use of consciousness energy healing based herbomineral formulation for skin anti-aging strategies. 5, 96-106.
J Singh, M Trivedi, A Branton, D Trivedi, G Nayak (2017) Consciousness energy healing treatment based herbomineral formulation: A safe and effective approach for skin health. 2, 1-10.
Dimitrius Anagnos, K Trivedi, A Branton, D Trivedi, G Nayak (2018) Influence of Biofield Treated Vitamin D3 on Proliferation, Differentiation, and Maturation of Bone-Related Parameters in MG-63 Cell-Line. 4(1), 6.
Lee Trivedi, K Branton, A Trivedi, D Nayak, G (2018) The potential benefits of biofield energy treated vitamin D3 on bone mineralization in human bone osteosarcoma cells (MG-63). 7, 30-38.
M Stutheit, K Trivedi, A Branton, D Trivedi, G Nayak (2018) Biofield Energy Treated Vitamin D3: Therapeutic Implication on Bone Health Using Osteoblasts Cells. 6(1), 13.
Hoda Aayadi, Smriti Mittal, Anjali Deshpande, Makargore, Saroj Ghaskadbi (2017) Cytoprotective effect exerted by geraniin in HepG2 cells is through microRNA mediated regulation of BACH-1 and HO-1. 50(11), 560-565.
Nayer Seyfizadeh, Farideh Elahimanesh, M Pouramir, E Zabihi, Narges Seyfizadeh, M Khosravi (2012) Evaluation of cytotoxicity induced by Pyrus boissieriana Buhse leaves extract in cell line Hep-G2. 44(13), S361-S362.
M Baggiolini, A Walz, S Kunkel (1989) Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.. 84(4), 1045-1049.
Henning Zimmermann, Sebastian Seidler, Nikolaus Gassler, Jacob Nattermann, Tom Luedde, Christian Trautwein, Frank Tacke (2011) Interleukin-8 Is Activated in Patients with Chronic Liver Diseases and Associated with Hepatic Macrophage Accumulation in Human Liver Fibrosis. 6(6), e21381.
Spiros Vlahopoulos, Istvan Boldogh, Antonella Casola, Allan Brasier (1999) Nuclear Factor-κB-Dependent Induction of Interleukin-8 Gene Expression by Tumor Necrosis Factor : Evidence for an Antioxidant Sensitive Activating Pathway Distinct From Nuclear Translocation. 94(6), 1878-1889.
L Gómez-Quiroz, L Bucio, V Souza, C Escobar, B Farfán (2003) Interleukin 8 response and oxidative stress in HepG2 cells treated with ethanol, acetaldehyde or lipopolysaccharide. 26(2), 134-141.
Daniel Pratt, Marshall Kaplan (2000) Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients. 342(17), 1266-1271.
U Mathiesen, L Franzén, A Frydén, U Foberg, G Bodemar (1999) The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. 11(4), 466.
Kai Simons, Robert Ehehalt (2002) Cholesterol, lipid rafts, and disease. 110(5), 597-603.
Munechika Enjoji, Kenichiro Yasutake, Motoyuki Kohjima, Makoto Nakamuta (2012) Nutrition and Alcoholic and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol. 523-532.
T Evans (2002) Review article: albumin as a drug-biological effects of albumin unrelated to oncotic pressure. 16(s5), 6-11.
Quinlan, Margarson Mumby, S Evans, T, Gutteridge (1998) Administration of albumin to patients with sepsis syndrome: A possible beneficial role in plasma thiol repletion. 95, 459-465.
Jean-Louis Vincent (2009) Relevance of albumin in modern critical care medicine. 23(2), 183-191.
M Garcovich, M Zocco, A Gasbarrini (2009) Clinical use of albumin in hepatology. 7(4), 268-277.
Rosaria Spinella, Rohit Sawhney, Rajiv Jalan (2016) Albumin in chronic liver disease: structure, functions and therapeutic implications. 10(1), 124-132.
Published
2019-01-04
Issue
Section
License
Copyright (c) 2018 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.